Silo Pharma, Inc.
Recent Filings
All 349 filings →| Form | Description | Date |
|---|---|---|
| 10-K | ANNUAL REPORT | Mar 27, 2026 |
| 8-K | CURRENT REPORT | Feb 23, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| SCHEDULE 13G/A | — | Feb 13, 2026 |
| 8-K | CURRENT REPORT | Dec 29, 2025 |
| 4 | — | Dec 16, 2025 |
| EFFECT | — | Nov 26, 2025 |
| 424B3 | PROSPECTUS | Nov 26, 2025 |
| 4 | — | Nov 21, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer | Purchase | 2,500 @ $0.41 | 214,432 | Dec 15, 2025 |
| Weisblum Eric | Chief Executive Officer | Purchase | 1,000 @ $0.37 | 211,932 | Nov 20, 2025 |
| Weisblum Eric | Chief Executive Officer | Purchase | 7,500 @ $0.40 | 205,432 | Nov 19, 2025 |
| Weisblum Eric | Chief Executive Officer | Purchase | 10,000 @ $0.43 | 197,932 | May 27, 2025 |
| Weisblum Eric | CEO and President | Purchase | 2,500 @ $0.84 | 187,932 | Dec 13, 2024 |
| Weisblum Eric | CEO and President | Purchase | 2,500 @ $0.95 | 182,932 | Nov 22, 2024 |
| Weisblum Eric | CEO and President | Purchase | 562 @ $1.08 | 175,994 | Jun 12, 2024 |
| Weisblum Eric | CEO and President | Purchase | 600 @ $1.96 | 175,032 | Apr 5, 2024 |
| Weisblum Eric | CEO and President | Purchase | 1,100 @ $1.91 | 174,432 | Mar 28, 2024 |
| Weisblum Eric | CEO and President | Purchase | 200 @ $1.61 | 169,924 | Dec 19, 2023 |